Skip to main content
Instructions for contributors
Editorial Policy and Scope

Global Health, Epidemiology and Genomics (GHEG) is an exciting new development from Cambridge Journals. It offers open access publication combined with peer-review standards set by an international editorial board of the highest calibre, all backed by Cambridge University Press and our commitment to quality.

GHEG aims to publish research that increases our understanding of human health and disease worldwide. Spanning both non-communicable and communicable diseases, GHEG will provide a platform to integrate population science, genomics and related technological advances in the global health context. Topics relevant to GHEG will include studies, methods and resources relating to disease aetiology, variation in disease susceptibility, drug resistance and surveillance, pharmacogenomics and stratified medicine, as well as the challenges of implementing new developments into clinical practice and the community, globally. We recognise the importance of the broader cultural, ethical and historical aspects of global health and populations and welcome contributions in these areas.

The field of global health, epidemiology and genomics is an emerging field which GHEG will facilitate by providing a forum for global discourse and the publication of new perspectives and paradigms. In this context, GHEG invites contributions from a range of disciplines and stakeholders, and covering a variety of research methods and analyses.

Submission of Manuscripts and Peer Review

All new submissions should be made through the ScholarOne site. If you are a new author, you will need to register:

GHEG uses a single-blind peer review process. Submitted manuscripts are reviewed by a member of the Editorial Board and at least two reviewers.

Open Access

All articles published by GHEG are Open Access: freely and permanently accessible online, immediately upon publication, under licensing that allows anyone to redistribute, re-use and adapt the content as long as they provide attribution.

Copyright and licensing

GHEG authors retain copyright over their work. They must complete and return a licence to publish form once their article has been accepted for publication. 

Authors must complete and return a licence to publish form once their article has been accepted for publication.

Articles will be published under a Creative Commons Attribution (CC-BY) licence as standard, but authors may elect to publish under the following alternative licences:

  • CC-BY-NC-SA (Attribution - Non-Commercial - Share Alike)
  • CC-BY-NC-ND (Attribution - Non-Commercial - No Derivatives)

For information on what each licence allows, please visit

For more information about OA, see Cambridge University Press’s open access policies pages.

Article processing charges

Open access publishing in GHEG is funded through levying an article processing charge (APC) on each individual author's institution or funding body.

An APC of £1,870 / $2,980 will apply to all accepted papers, with a waiver scheme for eligible countries - see waiver policy below for more details. The decision whether to accept a paper for publication will rest solely with the Editors, and without reference to the funding situation of the authors.

Please note: APC collection is managed by RightsLink, who will contact authors following acceptance of their paper. Authors of accepted papers which were submitted in 2016 and 2017 will be provided with a waiver code, but will still need to register with RightsLink.


Global Health, Epidemiology and Genomics now requires that all corresponding authors identify themselves using ORCID when submitting a manuscript to the journal. Joining ORCID is fast, free and you do not need to have a current affiliation. ORCID provides a unique identifier for researchers and, through integration in key research workflows such as publication and grant applications, provides the following benefits:

  • Discoverability: ORCID increases the discoverability of your publications, by enabling smarter publisher systems and by helping readers to reliably find work that you’ve authored.
  • Convenience: As more organisations use ORCID, providing your ID or using it to register for services will automatically link activities to your ORCID profile, and will save you re-keying information multiple times.
  • Keeping track: Your ORCID profile is a neat place to record and display (if you choose) validated information about your research activities.

If you don’t already have an ID, you’ll need to create one if you decide to submit a manuscript to Global Health, Epidemiology and Genomics. You can register for one directly from your user account on ScholarOne or Editorial Manager or via If you already have an ID, please use this when submitting by linking it to your ScholarOne user account. Simply log in to your account using your normal username and password. Edit your account by clicking on your name at the top right of the screen and from the dropdown menu, select 'E-Mail / Name'. Follow the instructions at the top of the screen to update your account.

For more information read this.

Subject Categories

During submission, authors must clearly indicate which of the below subject categories they are submitting their paper under. All papers, no matter what the article type, should be submitted under a subject category. If authors are uncertain under which category to submit their paper, they should contact the Editor-in-Chief, Manjinder Sandhu, at

  1. Epidemiology
  2. Genetics
  3. Statistical Methods
  4. Health Care Systems
  5. Policy and Society
  6. Technology
  7. Other
Themed Collections

The journal will also regularly publish themed collections of content. If your paper is being submitted in response to a Call for Papers for a themed collection, please indicate this in the cover letter upon submission. Details of themed collections currently open for submissions can be found here.

Article Types

In addition to Original Research Articles and Brief Reports, GHEG will accept structured Reviews, as well as Commentaries and Perspectives. The journal will also support submission of Protocols, Research Resources and Analysis. GHEG will also consider relevant Letters that respond to published papers. Guidelines for each article type, including word limits, are included below.

Publishing Ethics

Global Health, Epidemiology & Genomics and Cambridge University Press take issues of copyright infringement, plagiarism, or other breaches of best practice in publication very seriously. We seek to protect the rights of our authors and we always investigate claims of plagiarism or misuse of articles published in the journal. Equally, we seek to protect the reputation of the journal against malpractice. Submitted articles may be checked using duplication-checking software. Where an article is found to have plagiarised other work or included third-party copyright material without permission or with insufficient acknowledgement, or where authorship of the article is contested, we reserve the right to take action including, but not limited to: publishing an erratum or corrigendum (correction); retracting the article (removing it from the journal); taking up the matter with the head of department or dean of the author’s institution and/or relevant academic bodies or societies; banning the author from publication in the journal, or appropriate legal action. 

For further information on Cambridge's Ethical Guidelines, please visit these pages: Publication Ethics and Ethical Standards.

GHEG considers all manuscripts on the strict condition that:

  1. The manuscript is your own original work, and does not duplicate any other previously published work;
  2. The manuscript has been submitted only to the journal - it is not under consideration or peer review or accepted for publication or in press or published elsewhere;
  3. All listed authors know of and agree to the manuscript being submitted to the journal; and
  4. The manuscript contains nothing that is abusive, defamatory, fraudulent, illegal, libellous, or obscene.

The Journal adheres to the Committee on Publication Ethics (COPE) guidelines on research and publications ethics.

Text taken directly or closely paraphrased from earlier published work that has not been acknowledged or referenced will be considered plagiarism. Submitted manuscripts in which such text is identified will be withdrawn from the editorial process. If a concern is raised about possible plagiarism in an article submitted to or published in GHEG, this will be investigated fully and dealt with in accordance with the COPE guidelines.

Clinical Trials

As a condition of consideration for publication, registration of clinical trials in a public trials registry is required. A clinical trial is defined by the International Committee of Medical Journal Editors (in accordance with the definition of the World Health Organisation) as any research project that prospectively assigns human participants or groups of humans to one or more health- related interventions to evaluate the effects on health outcomes. Trials must be registered before the start of patient enrolment. The registry must be accessible to the public at no charge. It must be open to all prospective registrants and managed by a not-for-profit organization. There must be a mechanism to ensure the validity of the registration data, and the registry should be electronically searchable. An acceptable registry must include at minimum a unique trial number, trial registration date, secondary identification information if assigned by sponsors or others, funding source(s), primary and secondary sponsor(s), responsible contact person, research contact person, official scientific title of the study, research ethics review, the medical condition being studied, intervention(s), key inclusion and exclusion criteria, study type, anticipated trial start date, target sample size, recruitment status, primary outcome, and key secondary outcomes. Registration information must be provided at the time of submission. Trial registry name, registration identification number, and the URL for the registry should be included at the end of the abstract.

Manuscripts reporting the results of randomized controlled trials should include a "CONSORT" flow diagram as a figure in the manuscript to illustrate the progress of all patients in the study (See: Schulz KF, Altman D, for the CONSORT Group. The CON- SORT statement: revised recommendations for improving the quality of reports of parallel-group randomized trials. JAMA. 2001;285(15):1987–1991.)

Manuscript Preparation

Title page

The title page must include:

  1. The title of the article, which should be short but informative and accurately reflect the content;
  2. Authors' names and contact details: please list a brief affiliation for each author (assigned with superscript numbers) below the author names, and in addition, indicate the corresponding author with an asterisk and in this case provide a full postal address and email;
  3. A short running title for page headings (45 characters or less);
  4. At least four keywords or phrases;
  5. Word count, including all text but excluding tables, figures and references;
  6. Abstract (see below for details).


Every manuscript submitted for publication apart from commentaries and letters should include a concise, semi-structured abstract of no more than 150 words, summarising the main points of the article including the background, methods, results and conclusions (as appropriate to the manuscript type).


Original research articles:

Original research articles should pose and answer a clearly defined and justified research question and contribute to practice within the relevant field of work.

The main text of the article, excluding the abstract, tables, figures and references, should be no longer than necessary and between 2,000 – 4,000 words. The text should be divided into the following sections: Introduction, methods, results and discussion. Articles should contain no more than five display items (figures and / or tables).

Brief reports:

These papers are intended to be vehicles for valuable but limited or preliminary observations. The main text should not exceed 1,500 words and should, normally, include no more than three display items (figures and / or tables).


These papers should provide a comprehensive assessment of a particular topic or research area of broad interest. The length of the review article will depend on the scope of the subject area and its topicality, but generally articles should not exceed 6,000 words for the main text, and 150 references. Review submissions do not need to be formally divided into sub categories but should contain the same information as required for an original research article (introduction, methods, results and discussion) within the main body of the text.

Systematic reviews and meta-analyses must be reported following the PRISMA guidelines.


The journal accepts commentaries that discuss, criticise or develop themes relevant to the journal's scope. Commentaries are flexible in format but should be no more than 750 words. They should not be used as a means of publishing new work.


These are intended as papers of no more than 1,500 words that present and defend a clear stance on a particular topic related to the journal's scope.


We support and encourage publication of study protocols in relation to planned or on-going research programmes for which the required ethical approval has been obtained. Protocols should not be submitted, and will not be published, in relation to studies where data collection is already complete.

The main body of the paper should describe the rationale for and purpose of the study, provide a detailed description of the method used and analysis undertaken and discuss ethical considerations and any plans to share data. A protocol paper should be divided into the following sections: Introduction, broad method outline (including statistical analysis) and discussion. These submissions should not normally exceed 4,000 words.

Research Resources:

Research resources cover a broad range of papers which share and describe innovative databases, data resources or other tools of importance to the larger research community.

Examples of research resources suitable for submission include, but are not limited to: Data sets; Databases; Data collection tools (for example EQs); Legal and Ethical Frameworks to facilitate and conduct research; Study profiles; and Novel tools (for example governance framework documents). Please note that this is not an exhaustive list.

The format and structure of research resources will vary but in all cases the main body of text should be between 2000 – 4000 words.

Additional guidelines apply to the following categories of research resources:

Study profiles:

A study profile should bridge the gap between a protocol and original research article. In the event that baseline data has not yet been collected the paper should be submitted as a protocol.

A study profile should provide comprehensive information about the relevant study. Although there are no prescriptive requirements it may be useful to include information, as relevant, about the rationale and purpose of the study along with details about the study process; for example, the characteristics of study participants, demographic information, methods used and research questions posed. In relation to data you may wish to include details of the data collection phases, the main categories of data and data access and baseline results collected to date. A study profile may also explore any challenges faced, the strengths and limitations identified within the study as well as setting out future plans for the study.

Data resource:

Examples of a Data resource are:

  1. A collection of clinical information, epidemiological data including phenotypic as well as genetic data relevant to human global health; or
  2. A specific tool developed and used to collect data.

A data resource submitted for publication should, as applicable, describe the purpose of the data collection and provide details of participants, the type of data collected, data collection methods, data access and identify who and how the data can be used and in what context.

Governance framework resource:

Governance framework resources should describe:

  • The purpose for which the framework was drafted;
  • The methods used in developing the framework;
  • Any challenges addressed in developing the framework;
  • Any strengths and limitations identified with the framework;
  • Future plans for the framework.


An analysis should evaluate novel or contrasting methodologies, techniques and technologies or improvements to existing methods. The main text of an analysis should not exceed 2,000 words.


Letters responding to papers published by the journal are always welcome and readers are encouraged to submit these as soon as possible. Letters are flexible in format but should generally be limited to 500 words.

Figures and tables

Figures should be supplied as separate files in our preferred file formats, and figures should be saved at final publication size (please see a recent article in the journal for column widths). To ensure your figures are reproduced to the highest possible standards and your article is published as quickly and efficiently as possible, Cambridge Journals recommends the following formats and resolutions for supplying electronic figures. Please note that submitting low quality figures may result in a delay in publishing your valuable research.

Line artwork
Format: tif or eps
Colour mode: black and white (also known as 1-bit) Size: please size to final publication size
Resolution: 1200 dpi

Combination artwork (line/tone)
Format: tif or eps
Colour mode: grayscale (also known as 8-bit) Size: please size to final publication size
Resolution: 800 dpi

Black and white halftone artwork
Format: tif
Colour mode: grayscale (also known as 8-bit) Size: please size to final publication size
Resolution: 300 dpi

Colour halftone artwork
Format: tif
Colour mode: CMYK colour
Size: please size to final publication size
Resolution: 300 dpi

All wording within submitted figures must be Arial font, point size 8. Figure captions should be supplied at the end of the text of your article, and not as part of the figure files.

There are no charges for colour publication. Any figure provided in colour will be reproduced in colour online at no extra cost.

If you require any further guidance on creating suitable electronic figures, please visit the Cambridge Journals Artwork Guide.

Tables should be numbered consecutively in the text in Arabic numerals and each typed on a separate sheet after the References section. Titles should be typed above the table.


Number references consecutively in the order in which they are first mentioned in the text. Identify references in text, tables and legends by Arabic numerals in square brackets (not superscript numbers). References cited only in tables or in legends to figures should be numbered in accordance with a sequence established by the first identification in the text of the particular table or illustration.

'Unpublished observations' and 'personal communications' may not be used as references, although references to written, not oral, communications may be inserted (in parentheses) in the text. Include among the references papers accepted but not yet published, or published online only [supply Digital Object Identifier (doi) reference, if known]; designate the journal and add '(in press)'. Information from manuscripts submitted but not yet accepted should be cited in the text as 'unpublished observations'.

The references must be verified by the author(s) against the original documents.

The references section should be in numerical order. Examples follow:

Journal article

  1. Ramos E, et al. Pharmacogenomics, ancestry and clinical decision making for global populations.Pharmacogenomics Journal 2014; 14: 217-222.
  2. Capewell P, et al. A co-evolutionary arms race: trypanosomes shaping the human genome, humans shaping the trypanosome genome. Parasitology. Published online: 26 June 2014. doi:10.1017/S0031182014000602.
  3. Sandhu M. Building a forum for global health, epidemiology and genomics. Global Health, Epidemiology and Genomics 2015; 1: e1.


  1. Okpaku SO. Essentials of Global Mental Health. Cambridge: Cambridge University Press, 2014, pp. 56.

Book chapter

  1. Pang T. Infections, Genomics and Global Public Health. In: D. Kumar (eds). Genomics and Health in the Developing World. New York: Oxford University Press, 2012, pp. 152-156.

Note: authors' names should be in bold font and list all authors when three or fewer; when four or more, list only first author and add et al. Journal titles should always be given in full.

References to material published online should follow a similar style, with the URL included at the end of the reference, with the date of access, if known. Authors are requested to keep an archived copy of any online-only information, in case the URL changes or is no longer maintained. Examples follow:


  1. Global Alliance for Genomics and Health. Framework for Responsible Sharing of Genomic and Health-Related Data. ( Accessed 1 November 2014.
  2. World Health Organization. Community Genetics Services: Report of a WHO Consultation on community genetics in low-and middle-income countries. ( Accessed 9 January 2015.
Required Statements

The four sections below must be included. These statements should be included at the end of the manuscript, before the References section.


You may acknowledge individuals or organisations that provided advice, support (non-financial). Formal financial support and funding should be listed in the following section.

Financial Support

Please provide details of the sources of financial support for all authors, including grant numbers. For example, "This work was supported by the Medical research Council (grant number XXXXXXX)". Multiple grant numbers should be separated by a comma and space, and where research was funded by more than one agency the different agencies should be separated by a semi-colon, with 'and' before the final funder. Grants held by different authors should be identified as belonging to individual authors by the authors' initials. For example, "This work was supported by the Wellcome Trust (A.B., grant numbers XXXX, YYYY), (C.D., grant number ZZZZ); the Natural Environment Research Council (E.F., grant number FFFF); and the National Institutes of Health (A.B., grant number GGGG), (E.F., grant number HHHH)".

Where no specific funding has been provided for research, please provide the following statement: "This research received no specific grant from any funding agency, commercial or not-for-profit sectors."

Conflict of Interest

Please provide details of all known financial, professional and personal relationships with the potential to bias the work. Where no known conflicts of interest exist, please include the following statement: "None."

Ethical Standards

Where research involves human and/or animal experimentation, the following statements should be included (as applicable): "The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional committees on human experimentation and with the Helsinki Declaration of 1975, as revised in 2008." and "The authors assert that all procedures contributing to this work comply with the ethical standards of the relevant national and institutional guides on the care and use of laboratory animals."

Supplementary Material

Additional material (e.g. data sets, large tables) relevant to the paper can be submitted with your manuscript for publication online, where they are made available via a link from the paper. The paper should stand alone without these data. Supplementary Material must be cited in a relevant place in the text of the paper.

Please note that captions or legends should be included for all figures and tables in Supplementary Material. You should number figures or tables with the prefix 'S', e.g. Supplementary Figure S1, Supplementary Table S1. Colour images for online publication as Supplementary Material must be saved in RGB format.

Although Supplementary Material is peer reviewed, it is not checked, copyedited or typeset after acceptance and it is loaded onto the journal's website exactly as supplied. You should check your Supplementary Material carefully to ensure that it adheres to journal styles. Corrections cannot be made to the Supplementary Material after acceptance of the manuscript. Please bear this in mind when deciding what content to include as Supplementary Material.

Journal Style

Contributors should note the following:

  • S.I. units should be used throughout in text, figures and tables.
  • Authors should spell out in full any abbreviations used in their manuscripts.
  • Foreign quotations and phrases should be followed by a translation.
  • If necessary, guidelines for statistical presentation may be found in: Altman DG., Gore SM, Gardner, MJ. Pocock SJ. (1983). Statistical guidelines for contributors to medical journals. British Medical Journal 286, 1489-1493.
Developing country waiver policy

In line with other leading publishers, we grant 100% waivers to papers whose corresponding authors are based in Research4Life 'Group A' countries and 50% waivers to those who are based in 'Group B' countries.

Discretionary waiver policy
  1. (i) The author(s) must request a waiver at or before submission, before an article enters editorial consideration by contacting
  2. (ii) The author(s) must provide documentary evidence for their request.
  3. (iii) The waiver request should be processed by the Proprietor and/or CUP, without the knowledge of the editorial board.
  4. (iv) The waiver request should be processed as quickly as possible before the article moves from submission to editorial consideration
  5. (v) The decision to approve or decline the waiver request should be based on the credibility of the evidence the author provides and the author following the journal's waiver request procedure.
Waiver requests from Dutch authors

Information regarding Cambridge's arrangement with Dutch insitutions and other Cambridge University Press Open Access deals can be found here.

Editorial waiver policy

Waivers will be automatically granted for all:

  • Editorials
  • Invited Reviews (only if the author has no funding)
  • Errata/corrigenda
  • Correspondence

Full waivers will automatically be granted via RightsLink.


AuthorAID is a global network that provides free support, mentoring, resources and training to help researchers in low- and middle-income countries to write, publish and otherwise communicate their work.

Key features of AuthorAID are:

  • a community space for discussion and questions where researchers can benefit from advice and insights from members across the globe
  • access to a range of documents and presentations on best practice in writing and publication
  • world-wide training workshops and MOOCs on scientific writing
  • a chance to network with other researchers
  • personal mentoring by highly published researchers and professional editors

For any authors new to publishing research articles, we encourage you to make use of the AuthorAID resources before submitting your paper to GHEG. Through the AuthorAID network, guidance can be found to help researchers through the process of writing and submitting scientific papers, advice about responding to reviewer comments, as well as research design and grant applications.

Please note that seeking support through AuthorAID will not guarantee acceptance for publication in GHEG, or affect the editorial process in any way.

Cambridge Language Editing Service

We suggest that authors whose first language is not English have their manuscripts checked by a native English speaker before submission. This is optional, but will help to ensure that any submissions that reach peer review can be judged exclusively on academic merit. We offer a Cambridge service which you can find out more about here, and suggest that authors contact as appropriate. Please note that use of language editing services is voluntary, and at the author’s own expense. Use of these services does not guarantee that the manuscript will be accepted for publication, nor does it restrict the author to submitting to a Cambridge-published journal.

Digital Preservation Policy

Cambridge University Press publications are deposited in the following digital archives to guarantee long-term digital preservation:

  • CLOCKSS (journals)
  • Portico (journals and books)